Krystal Biotech, Inc. Common Stock vs. Sana Biotechnology, Inc. Common Stock
KRYS
Krystal Biotech, Inc. Common Stock
$347.00 +0.42%
VS SANASana Biotechnology, Inc. Common Stock
$3.13 +1.29%
Krystal Biotech, Inc. Common Stock (KRYS) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| KRYS | SANA | |
|---|---|---|
| Market Cap | $10.23 billion | $925.02 million |
| Revenue (TTM) | $440.48 million | — |
| Net Income (TTM) | $241.47 million | $-211,822,000 |
KRYS leads on 3 of 3 size & scale factors.
Valuation
| KRYS | SANA | |
|---|---|---|
| P/E Ratio | 43.48 | — |
| Price / Book | 7.53 | 5.98 |
| Price / Sales | 23.22 | — |
SANA leads on 1 of 1 valuation factors.
Profitability
| KRYS | SANA | |
|---|---|---|
| Net Margin | 54.82% | — |
| Return on Equity | 17.77% | -137.04% |
KRYS leads on 1 of 1 profitability factors.
Risk & Sentiment
| KRYS | SANA | |
|---|---|---|
| Short Interest | 0.11% | 0.18% |
KRYS leads on 1 of 1 risk & sentiment factors.
Dig deeper: KRYS overview, KRYS financials, SANA overview, SANA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.